78 related articles for article (PubMed ID: 18667019)
1. Prostate cancer survival: is there a dietary connection?
Holick MF
Nutr Rev; 2008 Jul; 66(7):425-6; author reply 427. PubMed ID: 18667019
[No Abstract] [Full Text] [Related]
2. Lifestyle therapy for prostate cancer: does it work?
Harv Mens Health Watch; 2007 Jul; 11(12):1-3. PubMed ID: 17687794
[No Abstract] [Full Text] [Related]
3. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence.
Van Patten CL; de Boer JG; Tomlinson Guns ES
J Urol; 2008 Dec; 180(6):2314-21; discussion 2721-2. PubMed ID: 18930254
[TBL] [Abstract][Full Text] [Related]
4. Diet and survival after prostate cancer diagnosis.
Berkow SE; Barnard ND; Saxe GA; Ankerberg-Nobis T
Nutr Rev; 2007 Sep; 65(9):391-403. PubMed ID: 17958206
[TBL] [Abstract][Full Text] [Related]
5. Re: Prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 randomized trial.
Schulz RJ; Kagan AR
J Natl Cancer Inst; 2009 Jan; 101(2):124. PubMed ID: 19141784
[No Abstract] [Full Text] [Related]
6. Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer, and confusion about the results of the randomized trials.
Roach M
J Clin Oncol; 2008 Aug; 26(22):3816-7; author reply 3817-8. PubMed ID: 18669477
[No Abstract] [Full Text] [Related]
7. Dietary intervention strategies to modulate prostate cancer risk and prognosis.
Freedland SJ; Aronson WJ
Curr Opin Urol; 2009 May; 19(3):263-7. PubMed ID: 19300265
[TBL] [Abstract][Full Text] [Related]
8. Diet and prostate cancer risk reduction.
Cheung E; Wadhera P; Dorff T; Pinski J
Expert Rev Anticancer Ther; 2008 Jan; 8(1):43-50. PubMed ID: 18095882
[TBL] [Abstract][Full Text] [Related]
9. Shedding new light on the etiology of prostate cancer?
Nomura A; Kolonel LN
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):409-10. PubMed ID: 8220083
[No Abstract] [Full Text] [Related]
10. Chemotherapy for prostate cancer in senior adults: are we treating the elderly or the frail?
Bellmunt J
Eur Urol; 2009 Jun; 55(6):1310-2. PubMed ID: 18778888
[No Abstract] [Full Text] [Related]
11. Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
Korfage IJ
Eur Urol; 2009 Feb; 55(2):432. PubMed ID: 18783875
[No Abstract] [Full Text] [Related]
12. What now on screening for prostate cancer?
Law M
J Med Screen; 2009; 16(3):109-11. PubMed ID: 19805750
[No Abstract] [Full Text] [Related]
13. Calcium, dairy, and prostate cancer.
Heaney RP
Br J Cancer; 2007 Mar; 96(6):1008; author reply 1009. PubMed ID: 17342083
[No Abstract] [Full Text] [Related]
14. Dietary intervention after definitive therapy for localized prostate cancer: results from a pilot study.
Parsons JK; Newman VA; Mohler JL; Pierce JP; Flatt S; Messer K; Marshall J
Can J Urol; 2009 Jun; 16(3):4648-54. PubMed ID: 19497171
[TBL] [Abstract][Full Text] [Related]
15. Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials.
Bria E; Cuppone F; Giannarelli D; Milella M; Ruggeri EM; Sperduti I; Pinnarò P; Terzoli E; Cognetti F; Carlini P
Cancer; 2009 Aug; 115(15):3446-56. PubMed ID: 19484790
[TBL] [Abstract][Full Text] [Related]
16. Re: Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial I. M. Thompson, C. M. Tangen, J. Paradelo, M. S. Lucia, G. Miller, D. Troyer, E. Messing, J. Forman, J. Chin, G. Swanson, E. Canby-Hagino and E. D. Crawford J Urol 2009; 181: 956-962.
Cheng T; Heng DY; Stewart D
J Urol; 2009 Nov; 182(5):2531-2; discussion 2532-4. PubMed ID: 19766252
[No Abstract] [Full Text] [Related]
17. Approaches to optimizing vitamin D therapy in prostate cancer.
Schwartz GG
J Urol; 2011 Apr; 185(4):1179-80. PubMed ID: 21334691
[No Abstract] [Full Text] [Related]
18. Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival?
Denham JW; Steigler A; Wilcox C; Lamb DS; Joseph D; Atkinson C; Tai KH; Spry NA; Gleeson PS; D'Este C
Cancer; 2009 Oct; 115(19):4477-87. PubMed ID: 19691097
[TBL] [Abstract][Full Text] [Related]
19. Re: Epilepsy-associated bone mineral density loss should be prevented.
Mikati MA; Ataya N; El-Hajj Fuleihan G
Neurology; 2009 Mar; 72(10):943; author reply 943-4. PubMed ID: 19273833
[No Abstract] [Full Text] [Related]
20. Screening for prostate cancer with serum prostate-specific antigen : what should we recommend while waiting for randomized clinical trial results?
Davis JW
Cancer; 2008 Dec; 113(11):3067-8. PubMed ID: 18932255
[No Abstract] [Full Text] [Related]
[Next] [New Search]
